BlackRock Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$54K Buy
2,829
+93
+3% +$1.78K ﹤0.01% 3240
2016
Q3
$61K Buy
2,736
+570
+26% +$10.7K ﹤0.01% 3194
2016
Q2
$40K Buy
2,166
+608
+39% +$10.5K ﹤0.01% 3278
2016
Q1
$28K Hold
1,558
﹤0.01% 3355
2015
Q4
$26K Sell
1,558
-1,353
-46% -$23K ﹤0.01% 3423
2015
Q3
$52K Buy
2,911
+34
+1% +$757 ﹤0.01% 3309
2015
Q2
$74K Buy
2,877
+457
+19% +$11.6K ﹤0.01% 3256
2015
Q1
$53K Buy
+2,420
New +$52.2K ﹤0.01% 3231

Other funds holding ENTL

BlackRock Advisors's ENTL Position: Q4 2016 in Review

BlackRock Advisors increased its Entellus Medical, Inc. Common Stock (ENTL) stake by 3.4% in Q4 2016, buying an estimated $1.78K and bringing the position to 2,829 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

BlackRock Advisors first reported a position in ENTL in Q1 2015 and has held it in 8 quarters since. The position peaked at $74K in Q2 2015. 63 funds tracked by Wall St. Rank hold ENTL as of Q4 2016.

  • BlackRock Advisors held 2,829 shares of Entellus Medical, Inc. Common Stock worth $54K as of Q4 2016.
  • BlackRock Advisors bought 93 Entellus Medical, Inc. Common Stock shares in Q4 2016, an estimated $1.78K.
  • Entellus Medical, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3240 holding.
  • BlackRock Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Advisors's Entellus Medical, Inc. Common Stock position peaked at $74K in Q2 2015.
  • 63 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.